Intellia Therapeutics, Inc. (NTLA) Stock Price & Analysis
Market: NASDAQ • Sector: Healthcare • Industry: Biotechnology
Intellia Therapeutics, Inc. (NTLA) Profile & Business Summary
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline includes NTLA-5001 for the treatment of acute myeloid leukemia; and proprietary programs focused on developing engineered cell therapies to treat various oncological and autoimmune disorders. In addition, it offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. Intellia Therapeutics, Inc. has license and collaboration agreements with Novartis Institutes for BioMedical Research, Inc. to engineer hematopoietic stem cells for the treatment of sickle cell disease; Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; Ospedale San Raffaele; and a strategic collaboration with SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases. The company was formerly known as AZRN, Inc. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Key Information
| Ticker | NTLA |
|---|---|
| Exchange | NASDAQ |
| Official Site | https://www.intelliatx.com |
Market Trend Overview for NTLA
One model, two time views: what the market looks like right now, and where the larger trend is heading over time.
SRE (WhaleQuant Structural Regime Engine) SRE evaluates how price structure evolves across daily and weekly timeframes to define the prevailing market regime. Beyond identifying trends, consolidations, and exhaustion phases, it distinguishes between raw structural strength and deployable participation quality. The model dynamically adjusts for structural context and extension risk, assessing whether conditions are supportive, stretched, fragile, or structurally impaired. Its purpose is not to forecast precise price levels, but to determine whether risk deployment is aligned with underlying market structure.
Longer-Term Market Trend (Mid to Long Term)
Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-11-06 (ET)
As of 2026-11-06, NTLA is moving sideways without a clear direction. Over the longer term, the trend remains bullish.
NTLA last closed at 11.35. The price is about 0.9 ATR below its recent average price (12.14), and the market is currently in a sideways market without a clear direction. Price at 11.35 is moving between light support near 11.33 and minor resistance near 12.31. Direction remains unclear. View Support & Resistance from Options
The market is moving sideways, with no clear direction. Both upside and downside risks remain in play.
Trend score: 35 out of 100. Overall alignment is unclear. The market is currently in a sideways market without a clear direction. The longer-term trend is still positive, but short-term signals are not yet confirming it.
A key downside risk boundary is near 11.26. If price falls below this area, the current structure would likely weaken further.
On 2026-11-05, trend conditions deteriorated, suggesting that moves in the prior direction became less dependable.
[2026-10-20] Price moved quickly and looked strong, but participation was limited.
Recent bars show mixed price behavior without a clear shift in structural quality or efficiency.
Closing activity showed limited conviction and did not suggest strong overnight positioning.
The model stays neutral because the setup is not clear enough to justify a directional deployment.
The model does not deploy this setup because predictability is still too low and price is still close to a gamma transition zone. Predictability is 26%, agreement is 85%, and reversal risk is 31%.
NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history
This estimate uses 1-minute price, volume, and VWAP data from the last 48 trading days, with turnover-based decay. The sample period is 2026-09-01 to 2026-11-06. The current price is 11.35, 5.74% below the estimated average cost of 12.04. An estimated 15.6% of recent positioning is below the current price, while 83.9% is above it. The peak-density price is 13.10. The largest concentrated cost region is 11.48 to 12.42 and contains 51.3% of the estimated distribution. The current price is within the 11.30 to 11.44 cost region. The nearest region below the current price is 11.09 to 11.27. The nearest region above the current price is 11.48 to 12.42.
Short Interest & Covering Risk for NTLA
This analysis looks at overall short interest positioning, focusing on the broader setup rather than short-term noise.
Shows how likely a short squeeze may be under current market conditions.
Short Exposure Percentile
Short interest is at a very high historical level. If price moves against shorts, reactions could be sharp and volatile. (Historical percentile: 91%)
Structure Analysis
NTLA Short positioning looks normal. Current days to cover is 6.5 trading days, meaning short positions could unwind at a normal pace. Short covering is likely to have a normal impact on price moves. Price is already trending lower (20D return -13.2%). The current configuration reflects active downside pressure rather than latent structural fragility.
Risk Summary
No clear bull trap characteristics detected. Recent price behavior remains broadly consistent with current positioning.This reading helps confirm that current price action remains structurally healthy and does not indicate elevated trap risk.
Why Price Reactions May Be Stronger?
Adaptive thresholds applied to liquidity weakness, near-high detection, and compression sensitivity. As a result, similar news or market events could lead to price moves about 1× larger than usual.
Note:
Short interest data is reported every two weeks by
FINRA.
The most recent snapshot is
2026-10-15 (ET).
Because this data updates slowly, it is not intended to predict short-term price moves. Instead, it helps describe longer-term market structure and where pressure may be building if prices begin to move.